Gorman Grainne S, Blakely Emma L, Hornig-Do Hue-Tran, Tuppen Helen A L, Greaves Laura C, He Langping, Baker Angela, Falkous Gavin, Newman Jane, Trenell Michael I, Lecky Bryan, Petty Richard K, Turnbull Doug M, McFarland Robert, Taylor Robert W
*Wellcome Trust Centre for Mitochondrial Research, Institute of Neuroscience, Newcastle University, Newcastle upon Tyne NE2 4HH, U.K.
‡The Walton Centre NHS Foundation Trust, Liverpool L9 7LJ, U.K.
Clin Sci (Lond). 2015 Jun;128(12):895-904. doi: 10.1042/CS20140705.
Complex I (CI) is the largest of the five multi-subunit complexes constituting the human oxidative phosphorylation (OXPHOS) system. Seven of its catalytic core subunits are encoded by mitochondrial DNA (ND (NADH dehydrogenase)1-6, ND4L (NADH dehydrogenase subunit 4L)), with mutations in all seven having been reported in association with isolated CI deficiency. We investigated two unrelated adult patients presenting with marked exercise intolerance, persistent lactic acidaemia and severe muscle-restricted isolated CI deficiency associated with sub-sarcolemmal mitochondrial accumulation. Screening of the mitochondrial genome detected novel mutations in the MTND1 (NADH dehydrogenase subunit 1) gene, encoding subunit of CI [Patient 1, m.3365T>C predicting p.(Leu20Pro); Patient 2, m.4175G>A predicting p.(Trp290*)] at high levels of mitochondrial DNA heteroplasmy in skeletal muscle. We evaluated the effect of these novel MTND1 mutations on complex assembly showing that CI assembly, although markedly reduced, was viable in the absence of detectable ND1 signal. Real-time PCR and Western blotting showed overexpression of different CI assembly factor transcripts and proteins in patient tissue. Together, our data indicate that the mechanism underlying the expression of the biochemical defect may involve a compensatory response to the novel MTND1 gene mutations, promoting assembly factor up-regulation and stabilization of respiratory chain super-complexes, resulting in partial rescue of the clinical phenotype.
复合体I(CI)是构成人类氧化磷酸化(OXPHOS)系统的五个多亚基复合体中最大的一个。其七个催化核心亚基由线粒体DNA编码(ND(NADH脱氢酶)1 - 6、ND4L(NADH脱氢酶亚基4L)),所有这七个亚基的突变都曾被报道与孤立性CI缺乏有关。我们研究了两名不相关的成年患者,他们表现出明显的运动不耐受、持续性乳酸性血症以及与肌膜下线粒体堆积相关的严重肌肉局限性孤立性CI缺乏。对线粒体基因组的筛查在骨骼肌线粒体DNA高异质性水平下,检测到MTND1(NADH脱氢酶亚基1)基因的新突变,该基因编码CI的亚基[患者1,m.3365T>C预测p.(Leu20Pro);患者2,m.4175G>A预测p.(Trp290*)]。我们评估了这些新的MTND1突变对复合体组装的影响,结果表明,尽管CI组装明显减少,但在没有可检测到的ND1信号的情况下仍可进行。实时PCR和蛋白质印迹显示患者组织中不同CI组装因子转录本和蛋白质的过表达。总之,我们的数据表明,生化缺陷表达的潜在机制可能涉及对新的MTND1基因突变的代偿反应,促进组装因子上调和呼吸链超复合体的稳定,从而部分挽救临床表型。